Sand Hill Global Advisors LLC Sells 24 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Sand Hill Global Advisors LLC trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,895 shares of the healthcare conglomerate’s stock after selling 24 shares during the quarter. Sand Hill Global Advisors LLC’s holdings in UnitedHealth Group were worth $1,524,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently modified their holdings of UNH. Norges Bank purchased a new stake in shares of UnitedHealth Group in the 4th quarter worth $5,802,231,000. International Assets Investment Management LLC increased its stake in UnitedHealth Group by 53,573.1% in the 4th quarter. International Assets Investment Management LLC now owns 2,352,490 shares of the healthcare conglomerate’s stock worth $1,238,515,000 after buying an additional 2,348,107 shares in the last quarter. Jennison Associates LLC increased its stake in UnitedHealth Group by 49.3% in the 4th quarter. Jennison Associates LLC now owns 3,617,813 shares of the healthcare conglomerate’s stock worth $1,904,670,000 after buying an additional 1,195,352 shares in the last quarter. Mawer Investment Management Ltd. increased its stake in UnitedHealth Group by 75.0% in the 3rd quarter. Mawer Investment Management Ltd. now owns 2,011,150 shares of the healthcare conglomerate’s stock worth $1,014,002,000 after buying an additional 862,024 shares in the last quarter. Finally, California Public Employees Retirement System increased its stake in UnitedHealth Group by 35.9% in the 4th quarter. California Public Employees Retirement System now owns 3,090,986 shares of the healthcare conglomerate’s stock worth $1,627,311,000 after buying an additional 815,822 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Trading Down 0.4 %

NYSE UNH traded down $2.14 during trading on Wednesday, hitting $521.41. The stock had a trading volume of 2,299,195 shares, compared to its average volume of 4,196,830. The stock has a market capitalization of $479.90 billion, a price-to-earnings ratio of 32.11, a P/E/G ratio of 1.50 and a beta of 0.55. The stock has a 50 day simple moving average of $487.65 and a 200 day simple moving average of $510.99. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $554.70. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. The business had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The company’s quarterly revenue was up 8.6% compared to the same quarter last year. During the same period last year, the company posted $6.26 earnings per share. Sell-side analysts predict that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were given a dividend of $1.88 per share. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.44%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 45.97%.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the company. Bank of America reiterated a “buy” rating and issued a $675.00 price target on shares of UnitedHealth Group in a research note on Thursday, March 7th. TD Cowen cut their price objective on UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating for the company in a research report on Wednesday, April 10th. Wells Fargo & Company cut their price objective on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a research report on Monday, April 8th. Morgan Stanley cut their price objective on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating for the company in a research report on Friday, April 5th. Finally, Erste Group Bank restated a “hold” rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. Three equities research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $570.05.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.